FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to oncology, and can be used for prediction of infiltrative breast cancer. Method involves a microscopic examination of a histologic preparation prepared from a tumour tissue selected from a patient, during which at least one type of T-lymphocyte infiltrating tumour is identified. CD4 T-lymphocytes are identified in a tumour stroma by conducting CD4-specific antigens using a biomarker that causes staining. Ratio of the number of stained cells in the stroma of the tumour is calculated to the total number of cells in the stroma of the tumour, the obtained relation is used for prognostic evaluation. If the above ratio is less than or equal to 50 %, the prognosis is considered to be favourable, while the patient's survival rate of 10 and more years is evaluated as a favourable prognosis.
EFFECT: using this method enables early detection of infiltrative breast cancer.
1 cl
Title | Year | Author | Number |
---|---|---|---|
BREAST CANCER PROGNOSIS METHOD | 2020 |
|
RU2748716C1 |
METHOD FOR MULTIVARIATE PROGNOSIS OF BREAST CANCER | 2021 |
|
RU2763839C1 |
METHOD FOR FORECAST OF BREAST CANCER | 2017 |
|
RU2664671C1 |
METHOD FOR CYTOLOGICAL DIAGNOSTICS AND PREDICTING THE FLOW OF WILMS TUMOR IN CHILDREN | 2001 |
|
RU2220416C2 |
METHOD FOR COMPLEX EVALUATION OF TUMOR SENSITIVITY TO CHEMOTHERAPY AT MAMMARY GLAND CANCER | 2001 |
|
RU2220418C2 |
METHOD FOR PREDICTING THE FLOW OF DISSEMINATED OVARIAN CANCER | 2006 |
|
RU2310203C1 |
METHOD OF PREDICTING NODAL METASTASIS IN TWO-WAY SYNCHRONOUS INVASIVE CARCINOMA OF NON-SPECIFIC TYPE OF MAMMARY GLANDS | 2015 |
|
RU2578462C1 |
METHOD FOR PREDICTING FIVE-YEAR SURVIVAL RATE IN PATIENTS WITH INFILTRATING BREAST CANCER BY DETERMINING TOTAL SCORE OF MALIGNANCY | 2013 |
|
RU2547561C1 |
METHOD FOR PREDICTION OF HAEMATOGENIC METASTASIS IN DOUBLE-SIDED SYNCHRONOUS INVASIVE NON-SPECIFIC BREAST CARCINOMA | 2015 |
|
RU2589287C1 |
INTRAOPERATIVE DIAGNOSIS METHOD FOR DETERMINING TUMOR PROCESS GENERALIZATION DEGREE IN THE CASES OF COLORECTAL CANCER | 2003 |
|
RU2248183C2 |
Authors
Dates
2019-08-19—Published
2018-07-10—Filed